Trastuzumab Terminated Phase 2 / 3 Trials for Metastatic Breast Cancer (MBC) Treatment

Indications	Status	Purpose	Phase
DBCOND0032947 (Metastatic Breast Cancer (MBC))	Terminated	Treatment	2 / 3

clinicaltrials.gov Identifier	Title	Drugs
NCT00216073	Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer	Oxaliplatin (DB00526) Trastuzumab (DB00072) Capecitabine (DB01101)